301211 Hubei Biocause Heilen Pharmaceutical

Watchlist

21.65
+1.82+9.18%

Noon Break Dec 23 11:30 CST

6.24BMarket Cap58.67P/E (TTM)

Hubei Biocause Heilen Pharmaceutical Key Stats

According to the latest financial report of Hubei Biocause Heilen Pharmaceutical, the latest earnings per share (TTM) for the company is 0.26. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Hubei Biocause Heilen Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 7.97.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hubei Biocause Heilen Pharmaceutical shows that the company's current ratio is 14.62, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the quick ratio is 13.41, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Hubei Biocause Heilen Pharmaceutical? The latest ROE figure is 3.21%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the total asset return on investment (ROA) is 3.00%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hubei Biocause Heilen Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 30.23%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the net profit margin is 22.35%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Henan Liliang Diamond

301071

36.05 +20.01%

Hangzhou SDIC Microelectronics Inc.